On May 16, 2025, former U.S. President Joe Biden was diagnosed with an aggressive form of prostate cancer, which has metastasized to his bones.

This diagnosis followed the identification of a small nodule on his prostate during medical examinations.

The prognosis for individuals with prostate cancer at an advanced stage, such as the fourth stage indicated in Biden's case, is concerning.

According to various medical analyses, the overall survival rate for individuals diagnosed with advanced prostate cancer can be as low as two to five years, depending on treatment availability and personal health factors.

Artificial intelligence assessments estimate that Biden faces approximately a 40% chance of living beyond five years following his diagnosis.

Despite the severity of the prognosis, there are options available.

Hormonal therapy may be considered to manage symptoms and extend life.

AI insights into cancer survival rates indicate that about 30-40% of patients with similar conditions live beyond five years, particularly if they have early-stage detection and access to advanced treatment options.

Earlier assessments from medical professionals have varied; for instance, former White House doctor Ronny Jackson suggested that Biden could have one to one and a half years of life remaining based on his health condition.

Following his diagnosis, Biden addressed the public through social media, sharing his personal battle with cancer, which he stated affects many others globally.

He expressed gratitude for the support from the community, emphasizing resilience in facing such personal health challenges.

Biden's health situation not only impacts his personal life but also raises questions about the implications for leadership and public service at an advanced age.

As the conversation around health and aging in politics continues, Biden's case highlights the ongoing challenges leaders face concerning their health and the public's expectations.